武汉大学第二临床学院研究生导师网页介绍
谢丛华
专业技术职称
教授，主任医师
院内行政职务
肿瘤放化疗科科主任
国外访学经历
法国南里昂中心医院放疗中心（1997.10－1998.10）
所在二级学科名称
临床医学
所在三级
学科名称
肿瘤学
导师主要研究方向
1.免疫放疗分子机制及临床策略研究
2.放射性肺损伤的分子机制及防治策略
主要学术兼职
（职务及聘任时间）
中华医学会放射肿瘤治疗学分会第九届委员会常委2017
中华医学会放射肿瘤治疗学分会第九届委员会免疫放疗学组组长2018
中国抗癌协会第五届肿瘤临床化疗专委会常委2019
中国抗癌协会肿瘤营养专委会放疗营养学组组长2018
中国医师协会放射肿瘤治疗医师分会第一届营养治疗专业委员会（学组）副主委2016
中国医师协会放射肿瘤治疗医师分会第二届委员会常委2019
中国研究型医院学会放射肿瘤学专业委员会常委2016
中国临床肿瘤学会非小细胞肺癌专家委员会常委2018
湖北省医学会放射肿瘤学会第五、六届委员会主委2017
湖北省抗癌协会肿瘤内科专委会主任委员2016
湖北省医师协会肿瘤分会第二届主任委员2018
主要社会兼职
（职务及聘任时间）
湖北名医工作室负责人 2019
中华放射肿瘤学杂志编委 2014
国际肿瘤学杂志副总编辑 2018
联系方式
办公室电话
027-67812960
Email
chxie_65@whu.edu.cn
近五年科研情况
近五年发表SCI及统计源以上期刊论文共 88 篇（本人为第一作者或通讯作者）
（其中SCI收录 62 篇，单篇论文最高SCI影响因子 24.799 分，累计影响因子 290.316 分）
目前承担的项目共 9 项（国家级 2 项）
近五年有代表性的论文、专著和获奖项等
序
号
成果（论文、专著、获奖项目）名称
成果鉴定、颁奖部门及奖励类别、等级或发表刊物与出版单位、时间
备注如：是否SCI（影响因子）
1
Outcomes in radiotherapy-treated patients with cancer during the COVID-19 outbreak in Wuhan, China
JAMA Oncology, 2020
24.799
2
SARS-COV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China
JAMA Oncology, 2020
24.799
3
The management of patients with lung cancer during the outbreak of coronavirus disease 2019
Journal of Thoracic Oncology, 2020
13.357
4
Alert to potential contagiousness: A case of lung cancer with asymptomatic severe acute respiratory syndrome coronavirus 2 infection
Journal of Thoracic Oncology, 2020
13.357
5
Treatment and outcome of a patient with lung cancer infected with severe acute respiratory syndrome coronavirus-2
Journal of Thoracic Oncology, 2020
13.357
6
The potential role of borophene as a radiosensitizer in boron neutron capture therapy (BNCT) and particle therapy (PT)
Biomaterials Science, 2020
6.183
7
Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China
Cancer, 2020
5.772
8
Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors
Cancer Communications, 2020
5.627
9
Downregulation of nitric oxide collaborated with radiotherapy to promote anti-tumor immune response via inducing CD8(+) T cell infiltration
International Journal of Biological Sciences, 2020
4.858
10
MFP-FePt-GO nanocomposites promote radiosensitivity of non-small cell lung cancer via activating mitochondrial-mediated apoptosis and impairing DNA damage repair
International Journal of Biological Sciences, 2020
4.858
11
Immunomodulation of NK cells by ionizing radiation
Frontiers in Oncology, 2020
4.848
12
The prognostic value of tumor mutational burden and immune cell infiltration in esophageal cancer patients with or without radiotherapy
Aging, 2020
4.831
13
A prognostic eight-gene expression signature for patients with breast cancer receiving adjuvant chemotherapy
Journal of Cellular Biochemistry, 2020
4.237
14
Establishment of the prognostic index of lung squamous cell carcinoma based on immunogenomic landscape analysis
Cancer Cell International, 2020
4.175
15
Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis
Scientific Reports, 2020
3.998
16
Establishment of the prognostic index reflecting tumor immune microenvironment of lung adenocarcinoma based on metabolism-related genes
Journal of Cancer, 2020
3.565
17
Risk factors of acquired T790M mutation in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer
Journal of Cancer, 2020
3.565
18
Pathologic evolution-related gene analysis based on both single-cell and bulk transcriptomics in colorectal cancer
Journal of Cancer, 2020
3.565
19
Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma
Cancer Medicine, 2020
3.491
20
Establishment of immune-related gene pair signature to predict lung adenocarcinoma prognosis using ESTIMATE algorithm
Cell Transplantation, 2020
3.341
21
Additional chemotherapy improves survival in stage II-III pulmonary sarcomatoid carcinoma patients undergoing surgery: a propensity scoring matching analysis
Annals of Translational Medicine, 2019
3.297
22
Systematic profiling of immune risk model to predict survival and immunotherapy response in head and neck squamous cell carcinoma
Frontiers in Genetics, 2020
3.258
23
Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer
BMC Cancer, 2020
3.15
24
Fear of disease progression and psychological stress in cancer patients under the outbreak of COVID-19
Psycho-Oncology, 2020
3.006
25
The characteristic of tumor immune microenvironment in pulmonary carcinosarcoma
Immunotherapy, 2020
2.964
26
Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial
Annals of Oncology, 2019
14.196
27
Locoregional control and mild late toxicity after reducing target volumes and radiation doses in patients with locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy (IC) followed by concurrent chemoradiotherapy: 10-year results of a Phase 2 study
International Journal of Radiation Oncology Biology Physics, 2019
6.203
28
Recent progress of nanoscale metal-organic frameworks in cancer theranostics and the challenges of their clinical application
International Journal of Nanomedicine, 2019
5.115
29
Fept/GO nanosheets suppress proliferation, enhance radiosensitization and induce autophagy of human non-small cell lung cancer cells
International Journal of Biological Sciences, 2019
4.858
30
Mir-195 restrains lung adenocarcinoma by regulating CD4+ T cell activation via the CCDC88C/Wnt signaling pathway: a study based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and bioinformatic analysis
Annals of Translational Medicine, 2019
3.297
31
Evaluation of the association between the -1304T>G polymorphism in the promoter of the MKK4 gene and the risk of colorectal cancer: a PRISMA-compliant meta-analysis
Annals of Translational Medicine, 2019
3.297
32
α-PD-L1 mAb enhances the abscopal effect of hypo-fractionated radiation by attenuating PD-L1 expression and inducing CD8+ T-cell infiltration
Immunotherapy, 2019
2.964
33
Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer
Cancer Medicine, 2019
3.491
34
Value of radiotherapy in addition to esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma: Analysis of surveillance, epidemiology, and end results database
Cancer Medicine, 2019
3.491
35
Small nucleolar RNA 71A promotes lung cancer cell proliferation, migration and invasion via MAPK/ERK pathway
Journal of Cancer, 2019
3.565
36
Impact of radiotherapy concurrent with anti-PD-1 therapy on the lung tissue of tumor-bearing mice
Radiation Research, 2019
2.657
37
Development of a hypoxic nanocomposite containing high-Z element as 5-fluorouracil carrier activated self-amplified chemoradiotherapy co-enhancement
Royal Society Open Science, 2019
2.515
38
Neutrophil-lymphocyte ratio dynamics are useful for distinguishing between recurrence and pseudoprogression in high-grade gliomas
Cancer Management and Research, 2019
2.243
39
Radiotherapy activates autophagy to increase CD8+ T cell infiltration by modulating major histocompatibility complex class-I expression in non-small cell lung cancer
Journal of International Medical Research, 2019
1.281
40
Fept-Cys nanoparticles induce ROS-dependent cell toxicity and enhance chemo-radiation sensitivity of NSCLC cells in vivo and in vitro
Cancer Letters, 2018
6.508
41
Protective role of nuclear factor-erythroid 2-related factor 2 against radiation-induced lung injury and inflammation
Frontiers in Oncology, 2018
4.137
42
Trichosanthin enhanced sensitivity of non-small cell lung cancer (NSCLC) TRAIL-resistant cells
International Journal of Biological Sciences, 2018
4.067
43
β-catenin decreases acquired TRAIL resistance in non-small-cell lung cancer cells by regulating the redistribution of death receptors
International Journal of Oncology, 2018
3.571
44
α7?nAchR agonist GTS?21 reduces radiation?induced lung injury
Oncology Reports, 2018
3.041
45
The change in peripheral blood monocyte count: A predictor to make the management of chemotherapy-induced neutropenia
Journal of Cancer Research and Therapeutics, 2018
1.392
46
PD-1 and PD-L1 expression in 132 recurrent nasopharyngeal carcinoma: the correlation with anemia and outcomes
Oncotarget, 2017
5.168
47
PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load
Scientific Reports, 2017
4.259
48
SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways
Oncology Reports, 2017
2.662
49
Simultaneous targeting PI3K and PERK pathways promotes cell death and improves the clinical prognosis in esophageal squamous carcinoma
Biochemical and Biophysical Research Communications, 2017
2.6619
50
HDAC6 promotes cell proliferation and confer resistance to temozolomide in glioblastoma
Cancer Letters, 2016
6.375
51
Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth
Oncotarget, 2016
5.168
52
The effect of the TLR9 ligand CPG-oligodeoxynucleotide on the protective immune response to radiation-induced lung fibrosis in mice
Molecular Immunology, 2016
3.236
53
HDAC6 promotes cell proliferation and confers resistance to gefitinib in lung adenocarcinoma
Oncology Reports, 2016
2.662
54
Radiation-induced autophagy promotes esophageal squamous cell carcinoma cell survival via the LKB1 pathway
Oncology Reports, 2016
2.486
55
HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells
Medical Oncology, 2016
2.486
56
β-catenin is regulated by USP9x and mediates resistance to TRAIL-induced apoptosis in breast cancer
Oncology Reports, 2016
2.486
57
Antagonism of mir-21 reverses radiation-induced EMT in alveolar epithelial cells via PI3K/Akt pathway
International Journal of Clinical and Experimental Pathology, 2016
1.706
58
Expression of beta-catenin and OPG in human non-small cell lung cancer and their clinical
International Journal of Clinical and Experimental Pathology, 2016
1.706
59
ATG7 promotes the tumorigenesis of lung cancer but might be dispensable for prognosis predication: a clinicopathologic study
OncoTargets and Therapy, 2016
1.653
60
Radiation-induced lung fibrosis in a tumor-bearing mouse model is associated with enhanced type-2 immunity
Journal of Radiation Research, 2016
1.536
61
Microrna-320 regulates the radiosensitivity of cervical cancer cells C33AR by targeting β-catenin
Oncology, 2016
1.39
62
A tumor marker panel scoring system to improve clinical stage in gastric cancer
International Journal of Clinical and Experimental Medicine, 2016
1.069
63
脑部放疗的选择对驱动基因阳性非小细胞肺癌脑转移患者生存的影响
中华放射医学与防护杂志，2020
64
局限期小细胞肺癌手术治疗的疗效分析及辅助治疗模式
中华肿瘤杂志，2020
65
去水淫羊藿黄素对非小细胞肺癌细胞的放射协同作用
武汉大学学报（医学版），2020
66
鼻咽癌调强放射治疗锁野计划对低剂量区的影响
武汉大学学报（医学版），2020
67
丝氨酸转运蛋白SFXN1在非小细胞肺癌中的表达及临床意义
肿瘤代谢与营养电子杂志，2020
68
非共面容积旋转调强在食管癌治疗中的应用
中国医学物理学杂志，2020
69
不同骨盆勾画及限量方式下宫颈癌术后IMRT计划的剂量学研究
医学放射物理，2019
70
胸段食管鳞癌术后复发模式及淋巴结复发规律
中华放射肿瘤学杂志，2019
71
Agrin在肿瘤免疫微环境中的研究进展
国际免疫学杂志，2019
72
放射治疗联合免疫疗法在癌症治疗中的研究进展
临床与病理杂志，2019
73
立体定向放疗应用于肺寡转移灶的疗效与预后
中华放射医学与防护杂志，2019
74
PBK和基质金属蛋白酶9在宫颈癌中的表达及对同步放化疗疗效的影响
中华放射医学与防护杂志，2018
75
FePt/GO纳米复合材料在放化疗中的应用
中国医学物理学杂志，2018
76
非小细胞肺癌甲状腺转移一例并文献复习
中华肺部疾病杂志，2018
77
绿色荧光蛋白标记的Lewis肺癌小鼠原位模型的建立及鉴定
武汉大学学报（医学版），
2018
78
化疗早期重度粒细胞下降与小细胞肺癌预后相关性分析
实用肿瘤学杂志，2018
79
小细胞肺癌的分子生物学研究进展
国际肿瘤学杂志，2018
80
头颈部肿瘤放疗者营养与支持治疗专家共识
中华放射肿瘤学杂志，2018
81
半胱胺修饰的FePt纳米颗粒对HeLa细胞的毒性
武汉大学学报（理学版），2017
82
肺寡转移瘤 SBRT疗效及预后因素分析
中华放射肿瘤学杂志，2017
83
抑制泛素特异性蛋白酶9X表达对胶质瘤U251细胞生长及凋亡的影响
武汉大学学报（医学版），2017
84
胸部放疗过程中胸肌体积的变化及其临床意义
实用肿瘤学杂志，2017
85
宫颈癌调强放疗后骨盆衰竭骨折的发生率
中华放射医学与防护杂志，2017
86
抑制泛素特异性蛋白酶9X表达对胶质瘤U251细胞生长及凋亡的影响
武汉大学学报（医学版），2017
87
胸部放疗过程中胸肌体积的变化及其临床意义
实用肿瘤学杂志，2017
88
程序性死亡分子1/程序性死亡分子1配体信号通路在肺癌细胞株上的表达及其生物学意义
中华实验外科杂志，2016
武汉大学第二临床学院研究生导师网页介绍
周福祥
专业技术职称
教授
主任医师
院内行政职务
无
国外访学经历
法国尼斯大学 2010.6
所在二级学科名称
肿瘤学
所在三级
学科名称
肿瘤放化疗及靶向治疗
导师主要研究方向
1、恶性肿瘤放化疗的基础与临床
2、恶性肿瘤分子分型与治疗敏感性
主要学术兼职
（职务及聘任时间）
中国抗癌协会肿瘤营养专业委员会常委兼代谢调节治疗学组副组长（2013年-至今）
中国临床肿瘤学会胆道肿瘤专委会常务委员（2019年-至今）
中华医学会放射肿瘤学分会第七届青年委员（2012年-2017）
中华医学会放射肿瘤学分会放射生物学组成员（2012年-至今）
湖北省药物与器械临床评价学会肿瘤诊疗专委会主任委员（2018年-至今）
湖北省抗癌协会肿瘤营养与代谢专业委员会主任委员（2016年-至今）
湖北省抗癌协会放射肿瘤专业委员会副主任委员(2013年-至今)
湖北省抗癌协会肿瘤分子标志专业委员会副主任委员(2013年-至今)
主要社会兼职
（职务及聘任时间）
《Gene Therapy》杂志特约审稿人（2012至今）
《肿瘤营养与代谢》杂志副主编（2014至今）
《中华放射医学与防护》杂志编委（2010至今）
国家科学技术奖励评审委员（2014至今）
国家食品药品监督管理局药品审评中心核查员（2016至今）
联系方式
办公室电话
027-67813155
Email
happyzhoufx@sina.com
近五年科研情况
发表中国科技论文与引文数据库（CSTPCD）期刊收录论文共48篇
（其中SCI收录33篇，单篇论文最高SCI影响因子6.402 分，累积影响因子87.709分）
目前承担的项目共 4项（国家级2项；省级2项）
拥有专利项目两项（排名第一和第三）
近五年有代表性的论文、专著和获奖项等
序
号
成果（论文、专著、获奖项目）名称
成果鉴定、颁奖部门及奖励类别、等级或发表刊物与出版单位、时间
备注如：是否SCI（影响因子）
1.
Predictive value of pancreatic dose-volume metrics on sarcopenia rate in gastric cancer patients treated with adjuvant chemoradiotherapy.
J Clin Nutr?2019 Aug;38(4):1713-1720. doi: 10.1016/j.clnu.2018.07.035
6..402,JCR医学2区top， 营养学1区
2.
Disruption of the menin-MLL interaction triggers menin protein degradation via ubiquitin-proteasome pathway.
Am J Cancer Res 2019;9(8):
4.737，医学 2区
3.
Fenofibrate-induced mitochondrial dysfunction and metabolic reprogramming reversal: the anti-tumor effects in gastric carcinoma cells mediated by the PPAR pathway
Am J Transl Res. 2020 Feb 15;12(2):428-446.()
3.402
4.
Long non-coding RNA 520 is a negative prognostic biomarker and exhibits pro-oncogenic function in nasopharyngeal carcinoma carcinogenesis through regulation of miR-26b-3p/USP39 axis. Gene.
2019 Jul 30;707:44-52. doi: 10.1016/j.gene.2019.02.093. Epub 2019 Mar 18.
?2.498
5.
Aberrant high expression level of MORC2 is a common character in multiple cancer
HUMAN PATHOLOGY，2018
3.125
6.
Development and validation of?an immunity-related classifier of?nine chemokines?for predicting recurrence in stage I-III patients with colorectal cancer after operation.
Cancer Manag Res, 2018 Volume 10: 4051—4064
3.702,医学二区
7.
4-Dimensional computed tomography analysis of clinical target volume displacement in adjuvant radiation of patients with gastric cancer and its implication on radiotherapy.
ONCOLOGY LETTERS. 2019, 17: 3641-3648,.
?1.664
8.
Prognostic Significance of Serum Lactic Acid, Lactate Dehydrogenase, and Albumin Levels in Patients with Metastatic Colorectal Cancer. ?
BioMed Research International,2018, https://doi.org/10.1155/2018/1804086
2.41
9.
Effects of different doses of X-ray irradiation on cell apoptosis, cell cycle, DNA damage repair and glycolysis in HeLa cells.
Oncology Letter, Oncol Lett.?2019 Jan;17(1):42-54. doi: 10.3892/ol.2018.9566
1.871
10.
Radiosensitization of clioquinol and zinc in human cancer cell lines
BMC Cancer,2018
3.288
11.
Mitochondrial Dysfunctions Regulated Radioresistance through Mitochondria-to-Nucleus Retrograde Signaling Pathway of NF-kappaB/PI3K/AKT2/mTOR
Radiation research,2018
2.539
12.
Mitochondrial DNA content reduction induces aerobic glycolysis and reversible resistance to drug-induced apoptosis in SW480 colorectal cancer cells.
Biomed Pharmacother.2018
3.457
13.
MORC2, a novel oncogene, is upregulated in liver cancer and contributes to proliferation, metastasis and chemoresistance.
Int J Oncol.2018
3.333
14.
2-Methoxyestradiol enhances radiosensitivity in radioresistant melanoma MDA-MB-435R cells by regulating glycolysis via HIF-1 alpha/PDK1 axis
Int J Oncol.2017
3.333
15.
Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis
ONCOTARGET,2017
5.168医学1区
16.
Downregulation of Mitochondrial Single Stranded DNA Binding Protein (SSBP1) Induces Mitochondrial Dysfunction and Increases the Radiosensitivity in Non-Small Cell Lung Cancer Cells.
J Cancer，2017
2.916
17.
Effect of captopril on radiation-induced TGF-β1 secretion in EA.Hy926 human umbilical vein endothelial cells.
Oncotarget.2017
5.168医学1区
18.
Heteroplasmy of mutant mitochondrial DNA A10398G and analysis of its prognostic value in non-small cell lung cancer.
Oncology Letters,2016
1.390
19.
D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy
Cancer Medicine,2016
3.362
20.
Optimal postoperative nutrition support for patients with gastrointestinal malignancy: A systematic review and meta-analysis.
Clin Nutr.2017
4.487
21.
Downregulation of Ubiquitin-conjugating Enzyme UBE2D3 Promotes Telomere Maintenance and Radioresistance of Eca-109 Human Esophageal Carcinoma Cells.
J Cancer，2016
3.609
22.
UBE2D3 gene overexpression increases radiosensitivity of EC109 esophageal cancer cells in vitro and in vivo.
Oncotarget.2016
5.003
23.
An association analysis between mitochondrial DNA content, G10398A polymorphism, HPV infection, and the prognosis of cervical cancer in the Chinese Han population.
Tumour Biol.2016
2.926
24.
The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121.
Biochem Biophys Res Commun.2015
2.371
武汉大学第二临床学院研究生导师网页介绍
魏永长
专业技术职称
主任医师
副教授
院内行政职务
科副主任，亚专科/病区主任
国外访学经历
2012.01-2013 MD Anderson肿瘤中心
2014.01-2014斯坦福国际研究院 博士后
所在二级学科名称
肿瘤学
所在三级
学科名称
放化疗
导师主要研究方向
1、肿瘤的微环境与放疗
2、肿瘤综合治疗
主要学术兼职
（职务及聘任时间）
1.湖北省临床肿瘤学会免疫治疗委员会副主任委员
2.湖北省抗癌协会肿瘤热疗专业委员会常务委员委
3.湖北省肿瘤精准医学研究中心免疫研究所副所长
4.湖北省抗癌协会肿瘤内科治疗专业委员会常委
联系方式
办公室电话
027-67811728
Email
weiyongchang8@163.com
近五年科研情况
近五年发表SCI及统计源以上期刊论文共16篇（本人为第一作者或通讯作者）
（其中SCI收录9篇，单篇论文最高SCI影响因子8.911分，累计影响因子 66.831 分）
目前承担的项目共 2项（国家级1项；省级 1项）
近五年有代表性的论文、专著和获奖项等
序号
成果（论文、专著、获奖项目）名称
成果鉴定、颁奖部门及奖励类别、等级或发表刊物与出版单位、时间
备注
如：是否SCI
（影响因子）
1
miR-15b-5p Promotes Growth and Metastasis in Breast Cancer by Targeting HPSE2
Front Oncol. 2020
4.137
2
Increasing the targeting scope and efficiency of base editing with Proxy-BE strategy
FEBS Lett. 2019
2.675
3
MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5
Front Oncol. 2019
4.137
4
TGF-β receptor inhibitor LY2109761 enhances the radiosensitivity of gastric cancer by inactivating the TGF-β/SMAD4 signaling pathway
Aging (Albany NY). 2019
5.515
5
Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway
Oxid Med Cell Longev. 2019
4.868
6
Therapeutic Potential of Natural Killer Cells in Gastric Cancer
Front Immunol. 2019
4.716
7
Let-7d inhibits growth and metastasis in breast cancer by targeting Jab1/Cops5
Cellular Physiology and Biochemistry，2018
5.104
8
Jab1/Csn5-thioredoxin signaling in relapsed acute monocytic leukemia under oxidative stress
Clinical Cancer Research, 2017，
8.911
9
P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
PLoS One. 2017
2.776
10
Potential prognostic value of clinical characteristics, hormone status and major depressive disorder in breast cancer
Future Oncology. 2017
2.279
11
Leptin-LepRb Expressed in Gastric Cancer Patients and Related to Cancer-Related Depression
Biomed Research International. 2017
2.197
12
Depression accelerates the development of gastric cancer through reactive oxygen species-activated ABL1 (Review)
Oncology Reports,
2016.
3.041
13
MicroRNAs serve as a bridge between oxidative stress and gastric cancer (Review)
International Journal of Oncology, 2016,
3.571
14
Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells
Oncotarget, 2016,
5.168
15
A novel curcuminoid exhibits enhanced antitumor activity in nasopharyngeal carcinoma
International Journal of Oncology, 2016
3.571
16
Expression and Diagnostic
Value of HE4 in Pancreatic
Adenocarcinoma
International Journal of Molecular Sciences,2015
4.183
17
大学生科研创新能力培养的实践及效果分析
中国医学教育技术，?
2015
第一作者
武汉大学第二临床学院研究生导师网页介绍
於海军
专业技术职称
副教授
副主任医师
院内行政职务
放化疗科副主任
国外访学经历
美国University of Oklahoma（2007-2009）和美国University of Florida (2019-2020)
所在二级学科名称
肿瘤学
所在三级
学科名称
肿瘤放射治疗学
导师主要研究方向
肿瘤放射治疗和免疫治疗
主要学术兼职
（职务及聘任时间）
中国临床肿瘤学会（CSCO）青年委员会委员 2018年
中国抗癌协会(CACA)青年理事会理事 2018
中国医师协会放疗医师分会青年委员会委员 2017年
湖北省临床肿瘤学会鼻咽癌专业委员会副主任委员2018年
湖北省临床肿瘤学会青年专家委员会副主任委员 2019
湖北省抗癌协会鼻咽癌委员会常务委员 2013年
湖北省抗癌协会肿瘤内科治疗委员会委员 2016年
湖北省抗癌协会肿瘤靶向治疗专委会委员 2015年
湖北省抗癌协会鼻咽癌专业委员会常委 2018年
湖北省临床肿瘤学会肿瘤免疫治疗专家委员会委员2018年
主要社会兼职
（职务及聘任时间）
无
联系方式
办公室电话
027-67811735
Email
doctoryhj@126.com
近五年科研情况
近五年发表SCI论文共11篇（本人为第一作者或通讯作者）
（其中SCI收录10篇，单篇论文最高SCI影响因子6.203分，累计影响因子超41分）
目前承担的项目共 5 项（国自然项目2项）
近五年有代表性的论文、专著和获奖项等
序
号
成果（论文、专著、获奖项目）名称
成果鉴定、颁奖部门及奖励类别、等级或发表刊物与出版单位、时间
备注如：是否SCI（影响因子）
1
Anti-tumor activity of zinc ionophore pyrithione in human ovarian cancer cells through inhibition of proliferation and migration and promotion of lysosome-mitochondrial apoptosis
Artificial Cells, Nanomedicine and Biotechnology 2020
4.462
2
Radiosensitization of Clioquinol Combined with Zinc in the Nasopharyngeal Cancer Stem-like Cells by Inhibiting Autophagy in Vitro and in Vivo
International Journal of Biological Sciences. 2020
4.858
3
A new registration algorithm of electronic portal imaging devices images based on the automatic detection of bone edges during radiotherapy
Scientific reports,2020
4.011
4
Dosimetric comparison of different algorithms in stereotactic body radiation therapy (SBRT) plan for non-small cell lung cancer (NSCLC)
OncoTargets and Therapy 2019
3.046
5
Risk Factors Analysis of Pathologically Confirmed Cervical Lymph Nodes Metastasis in Oral Squamous Cell Carcinoma Patients with Clinically Negative Cervical Lymph Node: Results from a Cancer Center of Central China.
Journal of Cancer. 2019
3.182
6
FDG/PET-CT-Based Supraclavicular Lymph Nodes Atlas in Breast Cancer Patients from Two Central China Cancer Centers.
Int J Radiat Oncol 2019
6.203
7
Radiosensitization of clioquinol and zinc in human cancer cell lines
BMC Cancer, 2018
3.288
8
The incidence and risk factors of hepatotoxicity induced by perioperative hyperthermic intraperitoneal chemotherapy in gastrointestinal carcinoma patients: a retrospective study.
OncoTargets and Therapy,2018
2.56
9
Radiosensitization of Clioquinol Combined with Zinc in the Nasopharyngeal Cancer Stem-Like Cells by Inhibiting Autophagy In Vitro and In Vivo.
Int J Radiat Oncol. 2018
6.203
10
Anticancer activity of Astragalus polysaccharide in human non-small cell lung cancer cells.
Cancer cell international,2017
3.96
11
A New Approach to Delineating Lymph Node Target Volumes for Post-Operative Radiotherapy in Gastric Cancer: A Phase II Trial.
Radiotherapy and Oncology, 2015
4.942
武汉大学第二临床学院研究生导师网页介绍
钟亚华
专业技术职称
主任医师/副教授
院内行政职务
放化疗科常务副主任
放化疗头颈乳腺专科主任
国外访学经历
2011年1月—2012年1月：美国Cleveland Clinic Foundation访问学者
所在二级学科名称
肿瘤学
所在三级
学科名称
肿瘤放化疗
导师主要研究方向
1.头颈、中枢神经系统放疗
2. 乳腺癌综合治疗
主要社会兼职
（职务及聘任时间）
中华医学会放射肿瘤学分会鼻咽癌组委员 2019
中华医学会放射肿瘤学分会青年委员会委员 2017
中国抗癌协会青年委员会委员 2017
中国医师协会脑胶质瘤委员会委员 2018
中国医师协会鼻咽癌放疗学组委员 2019
中国医师协会中枢神经肿瘤放疗学组委员 2019
中国生物医学工程学会精确放疗技术头颈肿瘤专委会常务委员 2019
中华医学会妇科肿瘤学分会第二届委员会青年委员会委员 2009
中国抗癌协会大肠癌专业委员会第一届青年委员会委员 2012
中国抗癌协会肿瘤营养与支持治疗专业委员会第一届青年委员会委员2014
湖北省抗癌协会肿瘤学专业委员会副秘书长 2016
湖北省医学会放射肿瘤分会第五届委员会秘书 2011
湖北省医学会鼻咽癌专业委员会副主委 2018
湖北省抗癌协会鼻咽癌专委会青委主委2018
湖北省抗癌协会青年委员会副主任委员 2013
湖北省肿瘤放射治疗质控中心副组长 2019
湖北省医学会鼻咽癌专业委员会常委 2018
湖北省乳腺甲状腺学会常务理事 2018
联系方式
办公室电话
027-67813154
Email
Doctorzyh73@163.com
近五年科研情况
发表中国科技论文与引文数据库（CSTPCD）期刊收录论文共 13 篇
（其中SCI收录 511 篇，单篇论文最高SCI影响因子5.742 分，累计影响因子 42.448 分）
主持承担的科研项目共 3 项
（国家级 1 项；省级 2 项；市级 0 项）
科研项目经费（博导仅计算武汉市及以上级别科研项目；硕导仅计算医学部、武汉大学、武汉市及以上级别科研项目，不包括院级）
纵向 25 万元，横向 0 万元，共计 25 万元（横向经费折算为10%计算）
3.006
3.006
3.006
3.006
3.006
1
Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China.
Cancer，2020
5.742
2
Primary Adenoid Cystic Carcinoma of the Upper Anterior Mediastinum Mimicking a Thyroid Tumor: A Case Report and Review of Literature.
Frontiers in Endocrinology，2020
3.644
3
Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
Cancer Communications
5.627
4
The impact of the COVID-19 pandemic on head and neck cancer patients.
Oral oncology
3.979
5
Fear of disease progression and psychological stress in cancer patients under the outbreak of COVID-19.
Psycho-oncology
3.006
6
A retrospective analysis on metastatic rate of the internal mammary lymph node and its clinical significance in adjuvant radiotherapy of breast cancer patients
BMC Cancer，2020
3.29
7
Neutrophil-lymphocyte ratio dynamics are useful for distinguishing between recurrence and pseudoprogression in high-grade gliomas.
CANCER MANAGEMENT AND RESEARCH，2019
2.42
8
Treatment Response Prediction of Nasopharyngeal Carcinoma Based on Histogram Analysis of Diffusional Kurtosis Imaging
AMERICAN JOURNAL OF NEURORADIOLOGY, Jan 2019
3.28
9
Prediction of IDH Status Through MRI Features and Enlightened Reflection on the Delineation of Target Volume in Low-Grade Gliomas,
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, Nov, 2019
1.48
10
Optimization of cervical lymph node clinical target volume delineation in nasopharyngeal carcinoma: a single center experience and recommendation
Oncotarget，2017
5.16
11
A new approach to delineating lymph node target volumes?for post-operative radiotherapy in gastric cancer: A phase II trial
Radiotherapy and Oncology, 2015
4.82
12
SD大鼠心脏局部照射放射性心肌纤维化模型建立
中华放射肿瘤学杂志,2017
13
减小非小细胞肺癌三维适形放射治疗靶体积可行性剂量学研究
临床外科杂志,2015
武汉大学第二临床学院研究生导师网页介绍
龚䶮
专业技术职称
副教授
院内行政职务
无
国外访学经历
2007-2013 缅因大学博士，2013-2017 哈佛大学医学院波士顿儿童医院博士后
所在二级学科名称
肿瘤学
所在三级
学科名称
肿瘤放化疗科学
导师主要研究方向
新生血管生成与脂代谢对肿瘤发生发展机制的基础及临床研究
主要学术兼职
（职务及聘任时间）
美国科学促进会、美国心脏协会、北美血管生物学学会、美洲华人生物科学学会、中国临床肿瘤协会、中国细胞生物学学会、中国生物化学与分子生物学学会会员
主要社会兼职
（职务及聘任时间）
武汉欧美同学会代表、武汉留学人员联谊会代表
联系方式
办公室电话
027-67811461
Email
yan.gong@whu.edu.cn
近五年科研情况
近五年发表SCI及统计源以上期刊论文共34篇（本人为第一作者或通讯作者）
（其中SCI收录34篇，单篇论文最高SCI影响因子6.607分，累计影响因子135.964分）
目前承担的项目共14项（国家级2项）
近五年有代表性的论文、专著和获奖项等
序
号
成果（论文、专著、获奖项目）名称
成果鉴定、颁奖部门及奖励类别、等级或发表刊物与出版单位、时间
备注如：是否SCI（影响因子）
1
Cytochrome P450 oxidase 2C inhibition adds to ω-3 long-chain polyunsaturated fatty acids protection against retinal and choroidal neovascularization
Arteriosclerosis, Thrombosis, and Vascular Biology、2016年9月
SCI、医学1区Top、IF=6.607
2
ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases
American Journal of Clinical Nutrition.、2017年7月
SCI、医学1区Top、IF=6.549
3
Fenofibrate inhibits cytochrome P450 epoxygenase 2C activity to suppress pathological ocular angiogenesis
EBioMedicine、2016年11月
SCI、医学1区Top、IF=6.183
4
A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy
Journal of Cellular Physiology、2020年5月
SCI、医学2区、IF=5.546
5
Weighted gene correlation network analysis identifies RSAD2, HERC5 and CCL8 as prognostic candidates for breast cancer
Journal of Cellular Physiology、2020年1月
SCI、医学2区、IF=5.546
6
TRIM8 inhibits breast cancer proliferation by regulating estrogen signaling
American Journal of Cancer Research、2020年11月
SCI、医学2区、IF=5.177
7
Co-transplantation with adipose-derived cells to improve parathyroid transplantation in a mice model
Stem Cell Research & Therapy、2020年5月
SCI、医学2区、IF=5.116，
8
Recent progress of nanoscale metal-organic framework in cancer theranostics and the challenges of their clinical application
International Journal of Nanomedicine、2019年12月
SCI、医学2区、IF=5.115
9
MFP-FePt-GO nanocomposites promote radiosensitivity of non-small cell lung cancer via activating mitochondrial-mediated apoptosis and impairing DNA damage repair
International Journal of Biological Sciences、2020年5月
SCI、医学2区、IF=4.858
10
Downregulation of nitric oxide collaborated with radiotherapy to promote anti-tumor immune response via inducing CD8+ T cell infiltration
International Journal of Biological Sciences、2020年3月
SCI、医学2区、IF=4.858
11
Overexpression of ASPM, CDC20 and TTK confer a poorer prognosis in breast cancer identified by gene co-expression network analysis
Frontiers in Oncology、2019年4月24日
SCI、医学2区、IF=4.848
12
Prognostic genes of breast cancer identified by gene co-expression network analysis
Frontiers in Oncology、2018年9月
SCI、医学2区、IF=4.848
13
The prognostic value of tumor mutational burden and immune cell infiltration in esophageal cancer patients with or without radiotherapy
Aging、2020年3月
SCI、医学2区、IF=4.831
14
A prognostic 10-lncRNA expression signature for predicting the risk of tumor recurrence in breast cancer patients
Journal of Cellular and Molecular Medicine、2019年10月
SCI、医学2区、IF=4.486
15
Establishment of the prognostic index of lung squamous cell carcinoma based on immunogenomic landscape analysis
Cancer Cell International、2020年7月
SCI、医学3区、IF=4.175
16
Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis
Scientific Reports、2020年10月
SCI、综合3区、IF=3.998
17
Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer
Journal of Cancer Research and Clinical Oncology、 2019年7月6日
SCI、生物3区、IF=3.656
18
β-catenin decreased acquired TRAIL resistance non-small-cell lung cancer cells by regulating the redistribution of death receptors
International Journal of Oncology、2018年11月
SCI、医学3区、IF=3.571
19
Establishment of the prognostic index reflecting tumor immune microenvironment of lung adenocarcinoma based on metabolism-related genes
Journal of Cancer、2020年11月
SCI、医学3区、IF=3.565
20
Pathologic evolution-related gene analysis based on both single-cell and bulk transcriptomics in colorectal cancer
Journal of Cancer、2020年10月
SCI、医学3区、IF=3.565
21
Small nucleolar RNA 71A promotes lung cancer cell proliferation, migration and invasion via MAPK/ERK pathway
Journal of Cancer、2019年5月
SCI、医学3区、IF=3.565
22
Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma
Cancer Medicine、2020年10月
SCI、医学3区、IF=3.491
23
Additional chemotherapy improves survival in stage II-III pulmonary sarcomatoid carcinoma patients undergoing surgery: a propensity scoring matching analysis
Annals of Translational Medicine、2020年11月
SCI、医学2区、IF=3.297
24
MiR-195 restrains lung adenocarcinoma by regulating CD4+ T cell activation via the CCDC88C/Wnt signaling pathway: a study based on the Cancer Atlas (TCGA), Gene Expression Ominibus (GEO) and bioinformatic analysis
Annals of Translational Medicine、2019年6月
SCI、医学2区、IF=3.297
25
Evaluation on the association between the -1304T>G polymorphism in the promoter of the MKK4 gene and the risk of colorectal cancer: a PRISMA-compliant meta-analysis
Annals of Translational Medicine、2019年4月
SCI、医学2区、IF=3.297
26
Optimization of an image-guided laser-induced choroidal neovascularization model in mice
PLOS ONE、2015年7月
SCI、综合3区、IF=3.057
27
The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER
OncoTargets and Therapy、2018年6月
SCI、医学3区、IF=3.046
28
Impact of Radiotherapy Concurrent with Anti-PD-1 Therapy on the Lung Tissue of Tumor-Bearing Mice
Radiation Research、2019年3月
SCI、医学3区、IF=2.657
29
Potential prognostic predictors and molecular targets for skin melanoma screened by weighted gene co-expression network analysis
Current Gene Therapy、2020年
SCI、医学4区、IF=2.431
30
Bioinformatic analysis and identification of potential prognostic microRNAs and mRNAs in thyroid cancer
PeerJ、2018年5月
SCI、生物3区、IF=2.353
31
Impact of gender and age on the prognosis of differentiated thyroid carcinoma: a retrospective analysis based on SEER
Hormones & Cancer、2018年10月
SCI、医学3区、IF=2.239
32
Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatment and long-term outcomes
World Journal of Surgical Oncology、2018年3月
SCI、医学4区、IF=1.966
33
Parathyroid autotransplantation at a novel site for better evaluation of the grafted gland function: study protocol for a prospective randomized controlled trial
Tails、2019年1月
SCI、医学4区、IF=1.883
34
Radiotherapy activates autophagy to increase CD8+ T cell infiltration by modulating major histocompatibility complex class-I expression in non-small cell lung cancer
Journal of International Medical Research、2019年6月
SCI、医学4区、IF=1.287
35
脂代谢与新生血管生成对肿瘤发生发展机制的基础及临床研究
武汉市卫生健康委员会、武汉中青年医学骨干人才培养工程、2019年5月
36
早产儿脂质代谢和视网膜病变
湖北省科学技术协会、湖北省青年科技晨光计划、2018年10月
37
新生血管生成与脂代谢对肿瘤发生发展机制的基础及临床研究
武汉大学中南医院、优秀中青年技术人才、2017年12月
删除或更新信息，请邮件至freekaoyan#163.com(#换成@)
武汉大学第二临床学院2021年硕士招生导师介绍（肿瘤学-放化疗）.doc
/2021-07-24
相关话题/
领限时大额优惠券,享本站正版考研考试资料!
优惠券领取后72小时内有效，10万种最新考研考试考证类电子打印资料任你选。涵盖全国500余所院校考研专业课、200多种职业资格考试、1100多种经典教材，产品类型包含电子书、题库、全套资料以及视频，无论您是考研复习、考证刷题，还是考前冲刺等，不同类型的产品可满足您学习上的不同需求。 ...考试优惠券 本站小编 Free壹佰分学习网 2022-09-19
